Necmi Eren

Crimean-Congo Hemorrhagic Fever in Turkey

S. Sami Kartı, Zekaver Odabaşı, Volkan Korten et al. · Emerging infectious diseases · 2004 · 307 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +16

Efficacy and safety of a targeted-release formulation of budesonide in patients with primary IgA nephropathy (NefIgArd): 2-year results from a randomised phase 3 trial

Richard Lafayette, Jens Kristensen, Andrew Stone et al. · The Lancet · 2023 · 289 citations · Full text

Medicine, Nephrology, Pharmacology +12

Mortality analysis of COVID-19 infection in chronic kidney disease, haemodialysis and renal transplant patients compared with patients without kidney disease: a nationwide analysis from Turkey

Savaş Öztürk, Kenan Turgutalp, Ali Rıza Odabaş et al. · Nephrology Dialysis Transplantation · 2020 · 235 citations · Full text

Medicine, Infectious Diseases, Nephrology +14

Results from part A of the multi-center, double-blind, randomized, placebo-controlled NefIgArd trial, which evaluated targeted-release formulation of budesonide for the treatment of primary immunoglobulin A nephropathy

Jonathan Barratt, Richard Lafayette, Jens Kristensen et al. · Kidney International · 2022 · 215 citations · Full text

Pharmacy, Nephrology, Pharmacotherapy +13

Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Sodium–Glucose Cotransporter 2 Inhibitor Treatment: The FIDELITY Analysis

Peter Rossing, Stefan D. Anker, Gerasimos Filippatos et al. · Diabetes Care · 2022 · 199 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17